Product News and Recalls

FDA Suggests Black Box Warnings for Victoza and Bydureon

victoza and bydureon may get black box warningsA pair of letters sent out in March by the FDA suggest that Novo Nordisk and AstraZeneca include black box warnings on the labels of their diabetes drugs, Victoza and Bydureon. The letters refer to previous notices sent by the FDA suggesting that the pharmaceutical companies include information about “the risk of medullary thyroid carcinoma” posed by the drugs. Accordingly, both Victoza and Bydureon now carry black box warnings about the risk of thyroid C-cell tumors.

Victoza is one of several diabetes medications in lawsuits in a multidistrict litigation in the Southern District of California. Alongside Byetta, Januvia, and Janumet, Victoza has been linked in several studies to cancer side effects that were not made public by the manufacturer. As a result, Victoza thyroid lawsuits have sprung up across the nation, claiming that the drugs caused patients to develop thyroid and pancreatic cancer.

Always consult your health care provider when switching medications. If you or someone you know was diagnosed with thyroid or pancreatic cancer after taking Victoza, Bydureon, Byetta, or Januvia, contact the lawyers at Lopez McHugh immediately to receive a free legal consultation. You may be eligible to pursue damages through a product liability lawsuit.